Leucinostatin A inhibits prostate cancer growth through reduction of insulin-like growth factor-I expression in prostate stromal cells

International Journal of Cancer

Volumn 126, Issue 4, 2010, Pages 810-818

  Kawada, Manabu ^a   Inoue, Hiroyuki ^a   Ohba, Shun Ichi ^a   Masuda, Tohru ^a   Momose, Isao ^a   Ikeda, Daishiro ^a  

^a Numazu Bio Medical Research Institute   (Japan)

Author keywords

IGF I; Natural compound; Prostate cancer; Prostate stroma; Tumor growth

Indexed keywords

ANTINEOPLASTIC AGENT; ATPENIN A; ATPENIN B; LEUCINOSTATIN A; LEUCINOSTATIN B; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DNA PRIMERS; HUMANS; MALE; MICE; MICE, NUDE; MITOCHONDRIA; MYCOTOXINS; PEPTIDES; PROSTATIC NEOPLASMS; PYRIDONES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS;

EID: 74049090004     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24915     Document Type: Article

References (37)

1. Stahtea XN, Roussidis AE, Kanakis I, Tzanakakis GN, Chalkiadakis G, Mavroudis D, Kletsas D, Karamanos NK. Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation. MT1-MMP expression and pro-MMP2 activation. Int J Cancer 2007;121:2808-14.
2. Wiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science 2002;296:1046-9.
3. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449:557-63.
4. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB, Logsdon CD. Cancerassociated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 2008;68:918-26.
5. Grossfeld GD, Hayward SW, Tlsty TD, Cunha GR. The role of stroma in prostatic carcinogenesis. Endocr Relat Cancer 1998;5: 253-70.
6. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 2002;8: 2912-23.
7. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-9.
8. Delinassios JG. Cytocidal effects of human fibroblasts on HeLa cells in vitro. Biol Cell 1987;59:69-77.
9. Picard O, Rolland Y, Poupon MF. Fibroblast-dependent tumorigenicity of cells in nude mice: implication for implantation of metastases. Cancer Res 1986;46:3290-4.
10. Camps JL, Chang SM, Hsu TC, Freeman MR, Hong SJ, Zhau HE, von Eschenbach AC, Chung LW. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci USA 1990;87:75-9.
11. Micke P, Ostman A. Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cancer 2004;45 (Suppl 2):S163-S175.
12. Tuxhorn JA, Ayala GE, Rowley DR. Reactive stroma in prostate cancer progression. J Urol 2001;166:2472-83.
13. Wernert N. The multiple roles of tumour stroma. Virchows Arch 1997;430:433-43.
14. Kawada M, Inoue H, Masuda T, Ikeda D. Insulin-like growth factor I secreted from prostate stromal cells mediates tumorstromal cell interactions of prostate cancer. Cancer Res 2006;66:4419-25.
15. Pollak M, Beamer W, Zhang JC. Insulinlike growth factors and prostate cancer. Cancer Metastasis Rev 1998;17:383-90.
16. Kiaris H, Trimis G, Papavassiliou AG. Regulation of tumor-stromal fibroblast interactions: implications in anticancer therapy. Curr Med Chem 2008;15: 3062-7.
17. Tsellou E, Kiaris H. Fibroblast independency in tumors: implications in cancer therapy. Future Oncol 2008;4: 427-32.
18. Date K, Matsumoto K, Kuba K, Shimura H, Tanaka M, Nakamura T. Inhibition of tumor growth and invasion by a fourkringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene 1998; 17:3045-54.
19. Kawada M, Ishizuka M, Takeuchi T. Enhancement of antiproliferative effects of interleukin-1b and tumor necrosis factor-a on human prostate cancer LNCaP cells by coculture with normal fibroblasts through secreted interleukin-6. Jpn J Cancer Res 1999;90:546-54.
20. Tuxhorn JA, McAlhany SJ, Yang F, Dang TD, Rowley DR. Inhibition of transforming growth factor-b activity decreases angiogenesis in a human prostate cancerreactive stroma xenograft model. Cancer Res 2002;62:6021-5.
21. Kawada M, Yoshimoto Y, Minamiguchi K, Kumagai H, Someno T, Masuda T, Ishizuka M, Ikeda D. A microplate assay for selective measurement of growth of epithelial tumor cells in direct coculture with stromal cells. Anticancer Res 2004;24: 1561-8.
22. Kawada M, Inoue H, Usami I, Ikeda D. Phthoxazolin A inhibits prostate cancer growth by modulating tumor-stromal cell interactions. Cancer Sci 2009;100:150-7.
23. Kawada M, Momose I, Someno T, Tsujiuchi G, Ikeda D. New atpenins, NBRI23477 A and B, inhibit the growth of human prostate cancer cells. J Antibiot 2009;62:243-6.
24. Kent RJ, Norris DE. Identification of mammalian blood meals in mosquitoes by a multiplexed polymerase chain reaction targeting cytochrome B. Am J Trop Med Hyg 2005;73:336-42.
25. Kawada M, Masuda T, Ishizuka M, Takeuchi T. 15-Deoxyspergualin inhibits Akt kinase activation and phosphatidylcholine synthesis. J Biol Chem 2002;277:27765-71.
26. Tartier L, Gilchrist S, Burdak-Rothkamm S, Folkard M, Prise KM. Cytoplasmic irradiation induces mitochondrialdependent 53BP1 protein relocalization in irradiated and bystander cells. Cancer Res 2007;67:5872-9.
27. Omura S, Tomoda H, Kimura K, Zhen DZ, Kumagai H, Igarashi K, Imamura N, Takahashi Y, Tanaka Y, Iwai Y. Atpenins, new antifungal antibiotics produced by Penicillium sp. Production, isolation, physico-chemical and biological properties. J Antibiot 1988;41:1769-73.
28. Kumagai H, Nishida H, Imamura N, Tomoda H, Omura S, Bordner J. The structures of atpenins A4. A5 and. B, new antifungal antibiotics produced by Penicillium sp. J Antibiot. 1990;43:1553-8.
29. Miyadera H, Shiomi K, Ui H, Yamaguchi Y, Masuma R, Tomoda H, Miyoshi H, Osanai A, Kita K, Omura S. Atpenins, potent and specific inhibitors of mitochondrial complex II (succinateubiquinone oxidoreductase). Proc Natl Acad Sci USA 2003;100:473-7.
30. Arai T, Mikami Y, Fukushima K, Utsumi T, Yazawa K. A new antibiotic, leucinostatin, derived from Penicillium lilacinum.. J Antibiot 1973;26:157-61.
31. Fukushima K, Arai T, Mori Y, Tsuboi M, Suzuki M. Studies on peptide antibiotics, leucinostatins. I. Separation, physicochemical properties and biological activities of leucinostatins A and B. J Antibiot 1983; 36:1606-12.
32. Fukushima K, Arai T, Mori Y, Tsuboi M, Suzuki M. Studies on peptide antibiotics, leucinostatins. II. The structures of leucinostatins A and B. J Antibiot 1983;36: 1613-30.
33. Kawada M, Inoue H, Arakawa M, Ikeda D. Transforming growth factor-b1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I. Anticancer Res 2008;28:721-30.
34. Shima A, Fukushima K, Arai T, Terada H. Dual inhibitory effects of the peptide antibiotics leucinostatins on oxidative phosphorylation in mitochondria. Cell Struct Funct 1990;15:53-8.
35. Lafkas D, Trimis G, Papavassiliou AG, Kiaris H. P53 mutations in stromal fibroblasts sensitize tumors against chemotherapy. Int J Cancer 2008;123: 967-71.
36. Bromfield GP, Meng A, Warde P, Bristow RG. Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill. Prostate Cancer Prostatic Dis 2003;6:73-85.
37. Li W, Wu CL, Febbo PG, Olumi AF. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells. Am J Pathol 2007;171:1189-98.